Drug profile · INN
damoctocog alfa pegol
JIVI
damoctocog alfa pegol (JIVI) is a coagulation factor viii exogenous protein.
EMA: approved PMDA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — damoctocog alfa pegol
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
damoctocog alfa pegol (JIVI) is a coagulation factor viii exogenous protein.
Key facts
INN damoctocog alfa pegol
Brand JIVI
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is damoctocog alfa pegol?
damoctocog alfa pegol (JIVI) is a coagulation factor viii exogenous protein.
What is the brand name for damoctocog alfa pegol?
JIVI is a marketed brand name for damoctocog alfa pegol. Check FDA Drugs@FDA for the current US label holder and prescribing information.